Ichor Holdings, Ltd. Announces First Quarter 2020 Financial Results
May 4, 2020
Highlights for the first quarter of 2020:
-
Revenues of
$220 million , up 16% sequentially and 60% year-over-year, and our fourth consecutive quarter of revenue growth; -
Net earnings of
$0.15 per diluted share on a GAAP basis and$0.52 on a non-GAAP basis; and - Earnings per share increased over 100% compared to the first quarter of 2019.
“During this unprecedented and challenging time, our top priority is to ensure the health and safety of our workforce and their families, while continuing to deliver exceptional service to our customers,” said
|
|
Q1 2020 |
|
|
Q4 2019 |
|
|
Q1 2019 |
|
|||
|
|
(dollars in thousands, except per share amounts) |
|
|||||||||
|
|
|||||||||||
Net sales |
|
$ |
220,028 |
|
|
$ |
189,355 |
|
|
$ |
137,831 |
|
Gross profit percent |
|
|
13.1 |
% |
|
|
13.7 |
% |
|
|
14.7 |
% |
Operating income percent |
|
|
2.5 |
% |
|
|
3.0 |
% |
|
|
2.1 |
% |
Net income |
|
$ |
3,399 |
|
|
$ |
7,952 |
|
|
$ |
1,518 |
|
Diluted EPS |
|
$ |
0.15 |
|
|
$ |
0.35 |
|
|
$ |
0.07 |
|
|
|
Q1 2020 |
|
|
Q4 2019 |
|
|
Q1 2019 |
|
|||
|
|
(dollars in thousands, except per share amounts) |
|
|||||||||
Non-GAAP Financial Results: |
|
|||||||||||
Net sales |
|
$ |
220,028 |
|
|
$ |
189,355 |
|
|
$ |
137,831 |
|
Gross profit percent |
|
|
13.8 |
% |
|
|
13.8 |
% |
|
|
14.9 |
% |
Operating income percent |
|
|
7.2 |
% |
|
|
7.1 |
% |
|
|
6.4 |
% |
Net income |
|
$ |
12,058 |
|
|
$ |
10,929 |
|
|
$ |
5,551 |
|
Diluted EPS |
|
$ |
0.52 |
|
|
$ |
0.48 |
|
|
$ |
0.25 |
|
For the first quarter of 2020, revenue was
Non-GAAP Financial Results Overview
For the first quarter of 2020, non-GAAP net income was
Second Quarter 2020 Financial Outlook
For the second quarter of 2020, we expect revenue to be in the range of
This outlook for non‑GAAP diluted EPS excludes known charges related to amortization of intangible assets, share‑based compensation expense, tax adjustments related to these non-GAAP adjustments, and non-recurring charges known at the time of providing this outlook. This outlook for non-GAAP diluted EPS excludes any items that are unknown at this time, such as non-recurring tax-related items or other unusual items which we are not able to predict without unreasonable efforts due to their inherent uncertainty.
COVID-19 Pandemic and Market Conditions Update
The COVID-19 pandemic and related economic repercussions have created, and are expected to continue to create, significant volatility, uncertainty, and turmoil in our industry. Government shutdowns and “social distancing” guidelines are, and will continue to, result in reduced factory capacity. In addition, an increase in direct costs within our factories associated with employee personal protective equipment (“PPE”), facility cleaning and layout changes, together with increases in logistics costs and employee labor costs, as well as other operating inefficiencies have resulted in, and may continue to result in, lower revenues and operating margins. The extent and duration of these impacts cannot be specifically quantified given the dynamic nature and breadth of the pandemic’s impact on our operations and that of our customers and suppliers.
Balance Sheet and Cash Flow Results
We ended the first quarter of 2020 with cash of
Our cash used in operating activities of
Use of Non-GAAP Financial Results
In addition to
Non-GAAP results have limitations as an analytical tool, and you should not consider them in isolation or as a substitute for our results reported under GAAP. Other companies may calculate non-GAAP results differently or may use other measures to evaluate their performance, both of which could reduce the usefulness of our non-GAAP results as a tool for comparison.
Because of these limitations, you should consider non-GAAP results alongside other financial performance measures and results presented in accordance with GAAP. In addition, in evaluating non-GAAP results, you should be aware that in the future we will incur expenses such as those that are the subject of adjustments in deriving non-GAAP results and you should not infer from our presentation of non-GAAP results that our future results will not be affected by these expenses or any unusual or non-recurring items.
Conference Call
We will conduct a conference call to discuss our first quarter 2020 results and business outlook on
To listen to a live webcast of the call, please visit our investor relations website at ir.ichorsystems.com, or go to the live link at webcasts.eqs.com/ichorholdings20200504. To listen via telephone, please call (877) 407‑0989 (domestic) or +1 (201) 389‑0921 (international), conference ID: 13702547.
After the call, an on-demand replay will be available at the same webcast link.
About Ichor
We are a leader in the design, engineering and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. Our product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. Our gas delivery subsystems deliver, monitor and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition. Our chemical delivery subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as chemical-mechanical planarization, electroplating, and cleaning. We also manufacture precision-machined components, weldments, and proprietary products for use in fluid delivery systems for direct sales to our customers, as well as certain components for internal use in fluid delivery systems and for direct sales to our customers. This vertically-integrated portion of our business is primarily focused on metal and plastic parts that are used in gas and chemical systems, respectively. We are headquartered in
We use a 52- or 53-week fiscal year ending on the last Friday in December. The three months ended
Safe Harbor Statement
Certain statements in this release are "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "guidance," "expects," "intends," "projects," "plans," "believes," "estimates," "targets," "anticipates," “look forward,” and similar expressions are used to identify these forward-looking statements.
Examples of forward-looking statements include, but are not limited to, statements regarding financial results for our second fiscal quarter of 2020, statements regarding the impacts of the COVID-19 pandemic, as well as any other statement that does not directly relate to any historical or current fact. Forward-looking statements are based on current expectations and assumptions, which may not prove to be accurate. These statements are not guarantees and are subject to risks, uncertainties and changes in circumstances that are difficult to predict. Many factors could cause actual results to differ materially and adversely from these forward-looking statements, including: (1) dependence on expenditures by manufacturers and cyclical downturns in the semiconductor capital equipment industry, (2) reliance on a very small number of original equipment manufacturers for a significant portion of sales, (3) negotiating leverage held by our customers, (4) competitiveness and rapid evolution of the industries in which we participate, (5) risks associated with weakness in the global economy and geopolitical instability, (6) keeping pace with developments in the industries we serve and with technological innovation generally, (7) designing, developing and introducing new products that are accepted by original equipment manufacturers in order to retain our existing customers and obtain new customers, (8) managing our manufacturing and procurement process effectively, (9) defects in our products that could damage our reputation, decrease market acceptance and result in potentially costly litigation, (10) dependence on a limited number of suppliers, and (11) the impact of the COVID‑19 pandemic, any related or unrelated public health threat or fear of such event on economic activity, us and our customers, suppliers, employees, and other business relations, including, but not limited to, demand for our products, workforce availability, and costs to manufacture our products. Additional information concerning these and other factors can be found in our filings with the
All forward-looking statements in this press release are based upon information available to us as of the date hereof, and qualified in their entirety by this cautionary statement. We undertake no obligation to update or revise any forward-looking statements contained herein, whether as a result of actual results, changes in our expectations, future events or developments, or otherwise, except as required by law.
|
||||||||
Consolidated Balance Sheets |
||||||||
(dollars in thousands, except per share amounts) |
||||||||
(unaudited) |
||||||||
|
|
2020 |
|
|
2019 |
|
||
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
41,583 |
|
|
$ |
60,612 |
|
Accounts receivable, net |
|
|
87,573 |
|
|
|
84,849 |
|
Inventories, net |
|
|
143,721 |
|
|
|
127,037 |
|
Prepaid expenses and other current assets |
|
|
6,868 |
|
|
|
4,449 |
|
Total current assets |
|
|
279,745 |
|
|
|
276,947 |
|
Property and equipment, net |
|
|
44,486 |
|
|
|
44,541 |
|
Operating lease right-of-use assets |
|
|
12,985 |
|
|
|
14,198 |
|
Other noncurrent assets |
|
|
1,084 |
|
|
|
1,094 |
|
Deferred tax assets, net |
|
|
4,016 |
|
|
|
4,738 |
|
Intangible assets, net |
|
|
48,693 |
|
|
|
52,027 |
|
|
|
|
173,010 |
|
|
|
173,010 |
|
Total assets |
|
$ |
564,019 |
|
|
$ |
566,555 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
119,076 |
|
|
$ |
131,578 |
|
Accrued liabilities |
|
|
12,071 |
|
|
|
12,814 |
|
Other current liabilities |
|
|
6,108 |
|
|
|
5,233 |
|
Current portion of long-term debt |
|
|
8,750 |
|
|
|
8,750 |
|
Current portion of lease liabilities |
|
|
5,432 |
|
|
|
5,492 |
|
Total current liabilities |
|
|
151,437 |
|
|
|
163,867 |
|
Long-term debt, less current portion, net |
|
|
172,359 |
|
|
|
169,304 |
|
Lease liabilities, less current portion |
|
|
7,962 |
|
|
|
9,081 |
|
Deferred tax liabilities |
|
|
210 |
|
|
|
210 |
|
Other non-current liabilities |
|
|
2,531 |
|
|
|
2,677 |
|
Total liabilities |
|
|
334,499 |
|
|
|
345,139 |
|
Shareholders’ equity: |
|
|
|
|
|
|
|
|
Preferred shares ( |
|
|
— |
|
|
|
— |
|
Ordinary shares ( |
|
|
2 |
|
|
|
2 |
|
Additional paid in capital |
|
|
247,023 |
|
|
|
242,318 |
|
|
|
|
(91,578 |
) |
|
|
(91,578 |
) |
Retained earnings |
|
|
74,073 |
|
|
|
70,674 |
|
Total shareholders’ equity |
|
|
229,520 |
|
|
|
221,416 |
|
Total liabilities and shareholders’ equity |
|
$ |
564,019 |
|
|
$ |
566,555 |
|
|
||||||||||||
Consolidated Statement of Operations |
||||||||||||
(dollars in thousands, except per share amounts) |
||||||||||||
(unaudited) |
||||||||||||
|
|
Three Months Ended |
|
|||||||||
|
|
2020 |
|
|
2019 |
|
|
2019 |
|
|||
Net sales |
|
$ |
220,028 |
|
|
$ |
189,355 |
|
|
$ |
137,831 |
|
Cost of sales |
|
|
191,254 |
|
|
|
163,440 |
|
|
|
117,608 |
|
Gross profit |
|
|
28,774 |
|
|
|
25,915 |
|
|
|
20,223 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
3,322 |
|
|
|
3,090 |
|
|
|
2,391 |
|
Selling, general, and administrative |
|
|
16,618 |
|
|
|
13,779 |
|
|
|
11,758 |
|
Amortization of intangible assets |
|
|
3,334 |
|
|
|
3,340 |
|
|
|
3,137 |
|
Total operating expenses |
|
|
23,274 |
|
|
|
20,209 |
|
|
|
17,286 |
|
Operating income |
|
|
5,500 |
|
|
|
5,706 |
|
|
|
2,937 |
|
Interest expense |
|
|
2,374 |
|
|
|
2,454 |
|
|
|
2,768 |
|
Other expense (income), net |
|
|
(31 |
) |
|
|
67 |
|
|
|
24 |
|
Income before income taxes |
|
|
3,157 |
|
|
|
3,185 |
|
|
|
145 |
|
Income tax benefit |
|
|
(242 |
) |
|
|
(4,767 |
) |
|
|
(1,373 |
) |
Net income |
|
|
3,399 |
|
|
|
7,952 |
|
|
|
1,518 |
|
Net income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.15 |
|
|
$ |
0.35 |
|
|
$ |
0.07 |
|
Diluted |
|
$ |
0.15 |
|
|
$ |
0.35 |
|
|
$ |
0.07 |
|
Shares used to compute net income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
22,737,163 |
|
|
|
22,555,666 |
|
|
|
22,269,827 |
|
Diluted |
|
|
23,181,127 |
|
|
|
22,993,767 |
|
|
|
22,536,209 |
|
|
||||||||||||
Consolidated Statements of Cash Flows |
||||||||||||
(in thousands) |
||||||||||||
(unaudited) |
||||||||||||
|
|
Three Months Ended |
|
|||||||||
|
|
2020 |
|
|
2019 |
|
|
2019 |
|
|||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
3,399 |
|
|
$ |
7,952 |
|
|
$ |
1,518 |
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
5,737 |
|
|
|
5,912 |
|
|
|
5,210 |
|
Share-based compensation |
|
|
2,865 |
|
|
|
3,940 |
|
|
|
1,330 |
|
Deferred income taxes |
|
|
722 |
|
|
|
(6,262 |
) |
|
|
3 |
|
Amortization of debt issuance costs |
|
|
243 |
|
|
|
241 |
|
|
|
212 |
|
Changes in operating assets and liabilities, net of acquisitions: |
|
|
— |
|
|
|
|
|
|
|
|
|
Accounts receivable, net |
|
|
(2,724 |
) |
|
|
(7,709 |
) |
|
|
(13,610 |
) |
Inventories, net |
|
|
(16,684 |
) |
|
|
(21,215 |
) |
|
|
6,935 |
|
Prepaid expenses and other assets |
|
|
(868 |
) |
|
|
2,575 |
|
|
|
1,357 |
|
Accounts payable |
|
|
(12,380 |
) |
|
|
44,553 |
|
|
|
895 |
|
Accrued liabilities |
|
|
(568 |
) |
|
|
2,553 |
|
|
|
(1,994 |
) |
Other liabilities |
|
|
(778 |
) |
|
|
(393 |
) |
|
|
(2,279 |
) |
Net cash provided by (used in) operating activities |
|
|
(21,036 |
) |
|
|
32,147 |
|
|
|
(423 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(2,470 |
) |
|
|
(3,995 |
) |
|
|
(4,782 |
) |
Net cash used in investing activities |
|
|
(2,470 |
) |
|
|
(3,995 |
) |
|
|
(4,782 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of ordinary shares under share-based compensation plans |
|
|
2,658 |
|
|
|
2,540 |
|
|
|
2,067 |
|
Employees' taxes paid upon vesting of restricted share units |
|
|
(993 |
) |
|
|
(68 |
) |
|
|
(111 |
) |
Repurchase of ordinary shares |
|
|
— |
|
|
|
— |
|
|
|
(1,599 |
) |
Borrowings on revolving credit facility |
|
|
5,000 |
|
|
|
8,000 |
|
|
|
5,000 |
|
Repayments on revolving credit facility |
|
|
— |
|
|
|
(6,000 |
) |
|
|
(8,000 |
) |
Repayments on term loan |
|
|
(2,188 |
) |
|
|
(2,187 |
) |
|
|
(4,375 |
) |
Net cash provided by (used in) financing activities |
|
|
4,477 |
|
|
|
2,285 |
|
|
|
(7,018 |
) |
Net increase (decrease) in cash |
|
|
(19,029 |
) |
|
|
30,437 |
|
|
|
(12,223 |
) |
Cash at beginning of period |
|
|
60,612 |
|
|
|
30,175 |
|
|
|
43,834 |
|
Cash at end of period |
|
$ |
41,583 |
|
|
$ |
60,612 |
|
|
$ |
31,611 |
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid during the period for interest |
|
$ |
2,136 |
|
|
$ |
2,309 |
|
|
$ |
3,255 |
|
Cash paid during the period for taxes, net of refunds |
|
$ |
34 |
|
|
$ |
(1,065 |
) |
|
$ |
107 |
|
Supplemental disclosures of non-cash activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures included in accounts payable |
|
$ |
652 |
|
|
$ |
774 |
|
|
$ |
958 |
|
Right-of-use assets obtained in exchange for new operating lease liabilities |
|
$ |
328 |
|
|
$ |
251 |
|
|
$ |
— |
|
|
||||||||||||
Reconciliation of |
||||||||||||
(dollars in thousands) |
||||||||||||
(unaudited) |
||||||||||||
|
|
Three Months Ended |
|
|||||||||
|
|
2020 |
|
|
2019 |
|
|
2019 |
|
|||
|
|
$ |
28,774 |
|
|
$ |
25,915 |
|
|
$ |
20,223 |
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation |
|
|
196 |
|
|
|
196 |
|
|
|
142 |
|
Other non-recurring expense, net (1) |
|
|
— |
|
|
|
— |
|
|
|
103 |
|
Contract settlement loss (2) |
|
|
1,386 |
|
|
|
— |
|
|
|
— |
|
Non-GAAP gross profit |
|
$ |
30,356 |
|
|
$ |
26,111 |
|
|
$ |
20,468 |
|
|
|
|
13.1 |
% |
|
|
13.7 |
% |
|
|
14.7 |
% |
Non-GAAP gross margin |
|
|
13.8 |
% |
|
|
13.8 |
% |
|
|
14.9 |
% |
(1) |
Included in this amount for all periods presented are costs associated with restructuring and transitioning key leadership roles. |
|
(2) |
During the first quarter of 2020, we reached a mutual settlement with the counterparty of a contract dispute and, accordingly, recorded a |
|
||||||||||||
Reconciliation of |
||||||||||||
(dollars in thousands) |
||||||||||||
(unaudited) |
||||||||||||
|
|
Three Months Ended |
|
|||||||||
|
|
2020 |
|
|
2019 |
|
|
2019 |
|
|||
|
|
$ |
5,500 |
|
|
$ |
5,706 |
|
|
$ |
2,937 |
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
|
3,334 |
|
|
|
3,340 |
|
|
|
3,137 |
|
Share-based compensation |
|
|
2,865 |
|
|
|
3,940 |
|
|
|
1,330 |
|
Other non-recurring expense, net (1) |
|
|
2,690 |
|
|
|
485 |
|
|
|
1,351 |
|
Contract settlement loss (2) |
|
|
1,386 |
|
|
|
— |
|
|
|
— |
|
Non-GAAP operating income |
|
$ |
15,775 |
|
|
$ |
13,471 |
|
|
$ |
8,755 |
|
|
|
|
2.5 |
% |
|
|
3.0 |
% |
|
|
2.1 |
% |
Non-GAAP operating margin |
|
|
7.2 |
% |
|
|
7.1 |
% |
|
|
6.4 |
% |
(1) |
Included in this amount for the first quarter of 2020 are (i) a |
|
|
Included in this amount for the fourth quarter of 2019 are (i) acquisition-related expenses, comprised primarily of expense associated with the IAN retention agreement, and (ii) non-capitalizable costs incurred in connection with our implementation of a new ERP system and a SOX compliance program. |
|
|
Included in this amount for the first quarter of 2019 are (i) acquisition-related expenses, comprised primarily of a charge to expense from the extinguishment of an indemnification asset related to our acquisition of Cal‑Weld in 2017 and expense associated with the IAN retention agreement, (ii) costs incurred in connection with reorganizing our key personnel and leadership, and (iii) non-capitalizable costs incurred in connection with our implementation of a new ERP system. |
|
(2) |
See footnote 2 on page 8. |
|
||||||||||||
Reconciliation of |
||||||||||||
(dollars in thousands, except per share amounts) |
||||||||||||
(unaudited) |
||||||||||||
|
|
Three Months Ended |
|
|||||||||
|
|
2020 |
|
|
2019 |
|
|
2019 |
|
|||
|
|
$ |
3,399 |
|
|
$ |
7,952 |
|
|
$ |
1,518 |
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
|
3,334 |
|
|
|
3,340 |
|
|
|
3,137 |
|
Share-based compensation |
|
|
2,865 |
|
|
|
3,940 |
|
|
|
1,330 |
|
Other non-recurring expense, net (1) |
|
|
2,690 |
|
|
|
485 |
|
|
|
1,351 |
|
Contract settlement loss (2) |
|
|
1,386 |
|
|
|
— |
|
|
|
— |
|
Tax adjustments related to non-GAAP adjustments (3) |
|
|
(1,616 |
) |
|
|
(4,788 |
) |
|
|
(1,785 |
) |
Non-GAAP net income |
|
$ |
12,058 |
|
|
$ |
10,929 |
|
|
$ |
5,551 |
|
|
|
$ |
0.15 |
|
|
$ |
0.35 |
|
|
$ |
0.07 |
|
Non-GAAP diluted EPS |
|
$ |
0.52 |
|
|
$ |
0.48 |
|
|
$ |
0.25 |
|
Shares used to compute diluted EPS |
|
|
23,181,127 |
|
|
|
22,993,767 |
|
|
|
22,536,209 |
|
(1) |
See footnote 1 on page 9. |
|
(2) |
See footnote 2 on page 8. |
|
(3) |
Adjusts |
|
||||||||||||
Reconciliation of |
||||||||||||
(in thousands) |
||||||||||||
(unaudited) |
||||||||||||
|
|
Three Months Ended |
|
|||||||||
|
|
2020 |
|
|
2019 |
|
|
2019 |
|
|||
Net cash provided by (used in) operating activities |
|
$ |
(21,036 |
) |
|
$ |
32,147 |
|
|
$ |
(423 |
) |
Capital expenditures |
|
|
(2,470 |
) |
|
|
(3,995 |
) |
|
|
(4,782 |
) |
Free cash flow |
|
$ |
(23,506 |
) |
|
$ |
28,152 |
|
|
$ |
(5,205 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200504005127/en/
IR@ichorsystems.com
Source: